To further clarify whether targeting SDF-1 can suppress EphA1-induced HCC growth and EPCs’ homing process, we established HLE cell xenograft models with different EphA1 levels in mice, which were then injected with EPCs through the tail vein on the post-xenograft 14th day. This evidence concerns the gene EPHA1 and hepatocellular carcinoma.